FUJIFILM SonoSite
SonoSite, Inc. specializes in hand-carried ultrasound technology, focusing on the rapidly expanding portable ultrasound market. The company leverages its expertise in Application-Specific Integrated Circuit (ASIC) design to provide imaging performance comparable to traditional, bulky ultrasound machines in a compact system resembling the size and weight of a laptop. This innovation significantly enhances the efficiency of existing clinical markets and facilitates new point-of-care applications in settings where traditional ultrasound was previously impractical due to size or cost. SonoSite's product offerings cater to a range of medical fields, including radiology, cardiology, vascular medicine, obstetrics, and gynecology, while also supporting emergency medicine, surgery, and critical care. Since its inception, SonoSite has sold over 40,000 systems, establishing a reputation for exceptional performance, durability, and ease of use in delivering safe and cost-effective imaging solutions in healthcare settings.
Carticept Medical focuses on developing healthcare therapies aimed at improving the quality of life for patients suffering from osteoarthritis and cartilage damage. The company offers a cartilage implant product and is involved in the distribution of Sonosite ultrasound products. Additionally, Carticept develops intra-articular steroid injections, which are administered directly into joints to alleviate pain and enhance mobility. These therapies enable patients to receive early treatment for osteoarthritis, ultimately supporting better musculoskeletal health and function.
Developer of ultrasound imaging systems focused on the advancement of human health research. The company's photoacoustic micro-imaging system offers a real-time assessment of blood oxygenation levels, contrast agents and optical dye visualizations in neurobiology, paediatrics and cancer diagnosis, thereby helping healthcare institutions in monitoring disease progressions in tissues for non-invasive treatments and drug delivery.
Carticept Medical focuses on developing healthcare therapies aimed at improving the quality of life for patients suffering from osteoarthritis and cartilage damage. The company offers a cartilage implant product and is involved in the distribution of Sonosite ultrasound products. Additionally, Carticept develops intra-articular steroid injections, which are administered directly into joints to alleviate pain and enhance mobility. These therapies enable patients to receive early treatment for osteoarthritis, ultimately supporting better musculoskeletal health and function.
LumenVu
Acquisition in 2007
LumenVu, Inc., a privately held, development stage company based in Philadelphia.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.